InsidersTradesSigma
Track the 영진약품 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 영진약품 has recorded 6 insider filings. Market capitalisation: €215.6bn. The latest transaction was filed on 5 March 2026 (Other). Among the most active insiders: 영진약품. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
영진약품是一家在XKRX市场上市的健康和制药公司。它专注于药品的研发和制造。